Sponsor: ECOG-ACRIN Cancer Research Group
Sponsor Study ID: EA8184
Study Title: A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers
CTO #: 103499
NCT Number: NCT04597359
Phase: II
Protocol Type: Prevention
Age Group: Adults
Disease Sites: Prostate
Study Objectives: This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.